The best place for doravirine
- PMID: 38141640
- DOI: 10.1016/S2352-3018(23)00326-0
The best place for doravirine
Erratum in
-
Correction to Lancet HIV 2024; 11: e64-65.Lancet HIV. 2024 Dec;11(12):e804. doi: 10.1016/S2352-3018(24)00091-2. Epub 2024 Mar 28. Lancet HIV. 2024. PMID: 38555921 No abstract available.
Conflict of interest statement
GG and CM received research grant and speaker honorariums from Gilead, ViiV, Merck, and Janssen. GG and CM attended advisory boards for Gilead, ViiV, and Merck. We thank Jovana Milic for drawing the table.
Comment on
-
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical